I just wonder if Kempler is in the process of applying an emergence acceptance when he talks about COVID-19 :
"Geoffrey Kempler, Alterity’s Chairman and CEO said: “Even without the effects Covid-19, antibiotic resistant pathogens kill more than 700,000 people each year and represent a major threat to global public health”.
This time could be a possibility to get this one step forward, but a company for that is needed.
ATH Price at posting:
3.1¢ Sentiment: None Disclosure: Held
